GGrantIndex
← Leaderboards

Sachin Patel

Medical College Of Wisconsin

$14,742,896
Attributed
$14,966,912
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,966,912 · 10

By mechanism

R01$13,049,540 · 4
R21$860,113 · 2
K08$842,032 · 1
F30$135,226 · 1
R13$80,001 · 2

Top collaborators

Most similar at Medical College Of Wisconsin

Same institution · by research overlap

Others in their field

Top investigators on “Endocannabinoids

Research focus

EndocannabinoidsAnxietySignal TransductionBrain2-ArachidonylglycerolNeuronsFunctional DisorderBaseSynapsesMediatingAmygdaloid StructurePhysiologicalBehavioralCnr1 GeneMood DisordersElectrophysiology (Science)GlutamatesIn VivoResponseBehaviorAnxiety DisordersNovel StrategiesInsightPlay

Grant awards (52)

2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$581,277
R01 · FY2025 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$360,000
R01 · FY2025 · AA · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$581,277
R01 · FY2024 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$360,000
R01 · FY2024 · AA · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$523,150
R01 · FY2023 · MH · contact PI
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction$483,588
R01 · FY2023 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$360,000
R01 · FY2023 · AA · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$552,213
R01 · FY2022 · MH · contact PI
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction$483,588
R01 · FY2022 · MH · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$628,506
R01 · FY2021 · MH · contact PI
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction$371,684
R01 · FY2021 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$289,707
R01 · FY2021 · AA · contact PI
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction$133,749
R01 · FY2021 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$109,773
R01 · FY2021 · AA · contact PI
2019 Cannabinoid Function in the CNS GRC & GRS$10,000
R13 · FY2021 · DA · contact PI
Annual Cannabinoid Research Society Symposium on the Cannabinoids$10,000
R13 · FY2021 · DA · contact PI
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction$540,834
R01 · FY2020 · MH · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$431,657
R01 · FY2020 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$399,480
R01 · FY2020 · AA · contact PI
ICRS Symposium on the Cannabinoids$12,500
R13 · FY2020 · DA · contact PI
2019 Cannabinoid Function in the CNS GRC & GRS$1
R13 · FY2020 · DA · contact PI
Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction$540,834
R01 · FY2019 · MH · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$431,657
R01 · FY2019 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$399,480
R01 · FY2019 · AA · contact PI
ICRS Symposium on the Cannabinoids$12,500
R13 · FY2019 · DA · contact PI
2019 Cannabinoid Function in the CNS GRC & GRS$10,000
R13 · FY2019 · DA · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$431,657
R01 · FY2018 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$403,507
R01 · FY2018 · AA · contact PI
Substrate-selective inhibition of COX-2 to target affective disorders$395,000
R01 · FY2018 · MH · contact PI
ICRS Symposium on the Cannabinoids$12,500
R13 · FY2018 · DA · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$431,657
R01 · FY2017 · MH · contact PI
Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders$409,953
R01 · FY2017 · AA · contact PI
Substrate-selective inhibition of COX-2 to target affective disorders$395,000
R01 · FY2017 · MH · contact PI
ICRS Symposium on the Cannabinoids$12,500
R13 · FY2017 · DA · contact PI
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation$453,072
R01 · FY2016 · MH · contact PI
Substrate-selective inhibition of COX-2 to target affective disorders$397,240
R01 · FY2016 · MH · contact PI
Substrate-selective inhibition of COX-2 to target affective disorders$390,000
R01 · FY2015 · MH · contact PI
Cycooxygenase-2 Inhibition for Cannabis Withdrawal and Relapse$201,718
R21 · FY2015 · DA
Afferent-specific Endocannabinoid Signaling in the Central Amygdala$196,250
R21 · FY2015 · MH · contact PI
Substrate-selective inhibition of COX-2 to target affective disorders$390,000
R01 · FY2014 · MH · contact PI
Cycooxygenase-2 Inhibition for Cannabis Withdrawal and Relapse$246,315
R21 · FY2014 · DA
Afferent-specific Endocannabinoid Signaling in the Central Amygdala$215,830
R21 · FY2014 · MH · contact PI
Stress adaptations in endocannabinoid signaling in the amygdala$166,838
K08 · FY2014 · MH · contact PI
Substrate-selective inhibition of COX-2 to target affective disorders$390,000
R01 · FY2013 · MH · contact PI
Stress adaptations in endocannabinoid signaling in the amygdala$166,838
K08 · FY2013 · MH · contact PI
Stress adaptations in endocannabinoid signaling in the amygdala$169,452
K08 · FY2012 · MH · contact PI
Stress adaptations in endocannabinoid signaling in the amygdala$169,452
K08 · FY2011 · MH · contact PI
Stress adaptations in endocannabinoid signaling in the amygdala$169,452
K08 · FY2010 · MH · contact PI
Cannabinoids and cortical-cerebellar function$42,722
F30 · FY2005 · DA
Cannabinoids and cortical-cerebellar function$32,119
F30 · FY2004 · DA
Cannabinoids and cortical-cerebellar function$31,170
F30 · FY2003 · DA
Cannabinoids and cortical-cerebellar function$29,215
F30 · FY2002 · DA